Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Bone|March 13, 2019
Oral dosing of pentoxifylline, a pan-phosphodiesterase inhibitor restores bone mass and quality in osteopenic rabbits by an osteogenic mechanism: A comparative study with human parathyroid hormoneSubhashis Pal, Konica Porwal, Kunal Khanna, et al.
The Journal of Nutritional Biochemistry|March 27, 2017
Guava fruit extract and its triterpene constituents have osteoanabolic effect: Stimulation of osteoblast differentiation by activation of mitochondrial respiration via the Wnt/β-catenin signalingKonica Porwal, Subhashis Pal, Kapil Dev, et al.
European Journal of Pharmacology|November 17, 2021
Adiponectin receptors by increasing mitochondrial biogenesis and respiration promote osteoblast differentiation: Discovery of isovitexin as a new class of small molecule adiponectin receptor modulator with potential osteoanabolic functionSubhashis Pal, Maninder Singh, Konica Porwal, et al.
Scientific Reports|January 15, 2020
A butanolic fraction from the standardized stem extract of Cassia occidentalis L delivered by a self-emulsifying drug delivery system protects rats from glucocorticoid-induced osteopenia and muscle atrophySubhashis Pal, Naresh Mittapelly, Athar Husain, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 6, 2014
The thiocarbamate disulphide drug, disulfiram induces osteopenia in rats by inhibition of osteoblast function due to suppression of acetaldehyde dehydrogenase activityMonika Mittal, Kainat Khan, Subhashis Pal, et al.
Biomedicines|July 27, 2024
Anti-Microbial Drug Metronidazole Promotes Fracture Healing: Enhancement in the Bone Regenerative Efficacy of the Drug by a Biodegradable Sustained-Release In Situ Gel FormulationShivali Duggal, Shivani Sharma, Nikhil Rai, et al.
Cytokine|April 8, 2018
M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasisRicha Shrivastava, Mohammad Asif, Varsha Singh, et al.
Journal of Medicinal Chemistry|September 26, 2025
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive MechanismsFarman M Abbasi, Konica Porwal, Subhashis Pal, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 17, 2016
IL-3 Decreases Cartilage Degeneration by Downregulating Matrix Metalloproteinases and Reduces Joint Destruction in Osteoarthritic MiceSupinder Kour, Manasa G Garimella, Divya A Shiroor, et al.
Scientific Reports|February 13, 2021
TRPM8 channel inhibitor-encapsulated hydrogel as a tunable surface for bone tissue engineeringTusar Kanta Acharya, Satish Kumar, Nikhil Tiwari, et al.
Pageof 5